An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma
Meijie Tian(National Institutes of Health), Javed Khan(Kent State University), Xiaolin Wu(Jiamusi University), Mehdi Benzaoui(Centre National de la Recherche Scientifique), Yong Kim(National Institutes of Health), Katherine E. Masih(National Institutes of Health), Michael C. Kelly(National Cancer Institute), Christopher M. Dower(Center for Cancer Research), Mitchell Ho(National Institutes of Health), Jun S. Wei(Center for Cancer Research), Abdalla Abdelmaksoud(National Cancer Institute), Zhongmei Zhang(National Cancer Institute), Jerry T. Wu(National Cancer Institute), Brad St. Croix(National Cancer Institute), David Milewski(National Cancer Institute), Hsien-Chao Chou(National Cancer Institute), Haiying Qin(National Institutes of Health), Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Nan Li(National Institutes of Health), Naomi Taylor(National Institutes of Health), S. Badr(Center for Cancer Research), Xinyu Wen(National Institutes of Health)
Cited by 72
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563